Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21

Benzinga Newsdesk www.benzinga.com Neutral 70.5%

Neg 0% Neu 70.5% Pos 0%

Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.